The flip side of the hot IPO market? A chill could trigger a sudden cash crunch in biotech, followed by more deals
Over the last 5 years biotech IPOs and follow-ons have raised a tsunami of cash totaling some $128 billion, according to a new estimate out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
